VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1712972
Sex: F
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/06/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Shingles - left arm palm and fingers; pain in left shoulder and neck; pain in left shoulder and neck; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN5318, Expiration date: not reported), via an unspecified route of administration in arm left on 02Feb2021 at 15:00 (at the age of 74-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was reported as unknown. The patient had any known allergies were reported as unknown. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL1283, Expiration date: not reported), via an unspecified route of administration in arm right on 12Jan2021 (at the age of 74-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. Covid prior vaccination and Covid tested post vaccination was reported as unknown. On 06Feb2021, the patient experienced pain in left shoulder and neck, then went to emergency room on 13Feb2021 and diagnosed with Shingles - left arm palm and fingers. The AE resulted in emergency room/department or urgent care. Treatment was received for the events and treatment medications included valtrex, prednisone, gabapentin. The outcome of the events was recovered on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1712973
Sex: F
Age:
State: NY

Vax Date: 02/22/2021
Onset Date: 03/08/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Got shingles 2 weeks after covid vaccine; This is a spontaneous report from a contactable consumer (patient herself) via COVID-19 Adverse Event Self-Reporting Solution. A 46 years old non -pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: 6198) via an unspecified route, administered in Left Arm on 22Feb2021 at 14:15 (46-year-old at vaccination) as a Dose number unknown, Single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient medical history was not reported. No known allergies was reported. The patient's concomitant medication(s) included semaglutide (OZEMPIC), bupropion hydrochloride (WELLBUTRIN) within two weeks of vaccination. Vaccination Facility type was reported as Other. The patient was not diagnosed with Covid prior vaccination. The patient had not received any other vaccine in four weeks prior vaccination. On 03Mar2021 (2 weeks after covid vaccine), the patient had experienced shingles. These adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care visit. The patient received Lyrica, acyclovir as treatment medication for the event. The patient had not tested for Covid post vaccination. The outcome of the event shingles was recovering. No follow-up attempts are required. No further information is expected.

Other Meds: OZEMPIC; WELLBUTRIN

Current Illness:

ID: 1712974
Sex: F
Age:
State: AZ

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: shingles rash; shingles rash; sharp piercing pain across my upper left chest; heat attack; Had throbbing and soreness in left upper chest; This is a spontaneous report from a contactable consumer (patient herself). A 66-years-old non-pregnant female patient received second dose of bnt162b2 (Solution injection, Batch/Lot Number: EL9269), via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 12:15 (at the age of 66-years-old) as single dose for covid-19 immunisation. Patient previously received first dose of bnt162b2 (Solution injection, Batch/Lot Number: EL3249), via an unspecified route of administration, administered in Arm Left on 19Jan2021 at 17:00 as single dose for covid-19 immunisation. Medical history included shingles. Patient had no known allergies. Concomitant medications included lorazepam, valacyclovir, atorvastatin and trazodone. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with covid prior vaccination. Patient was not tested for covid post vaccination. On 12Feb2021 at 12:15, patient experienced sharp piercing pain across her upper left chest. For the following two months pain would come and go without any pattern. She was having a heat attack. Had throbbing and soreness in left upper chest and also dull pain at various times for two months after shot. Doctors were giving her many tests. Two months after shot broke out in a shingles rash in that exact same. The outcome of the events was unknown.

Other Meds: LORAZEPAM; VALACYCLOVIR HCL; ATORVASTATIN; TRAZODONE

Current Illness:

ID: 1712975
Sex: M
Age:
State: WI

Vax Date: 03/09/2021
Onset Date: 03/12/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210420; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Alopecia areata; Sudden hair loss in patches on scalp and beard; This is a spontaneous report from a contactable consumer or other non hcp. A 26-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN6199) via an unspecified route of administration in Arm Left on 09Mar2021 (age at vaccination 26years old) as single dose for covid-19 immunisation. Medical history included testis cancer, drug hypersensitivity, all from an unknown date and unknown if on-going. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included famotidine (FAMOTIDINE); lysine (LYSINE); calcium carbonate (TUMS [CALCIUM CAR-BONATE]), all taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had been tested for COVID-19. On 12Mar2021 the patient experienced alopecia areata, sudden hair loss in patches on scalp and beard. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 20Apr2021. The patient received treatment with steroid cream for the adverse events. The clinical outcome of the event was not recovered. Therapeutic measures were taken as a result of alopecia areata, sudden hair loss in patches on scalp and beard. No follow-up attempts are needed. No further information is expected.

Other Meds: FAMOTIDINE; LYSINE; TUMS [CALCIUM CARBONATE]

Current Illness:

ID: 1712976
Sex: F
Age:
State: IL

Vax Date: 03/30/2021
Onset Date: 04/02/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Shingles that started 3 days following the 1st vaccine administration.; This is a spontaneous report from a contactable consumer (Patient). A 52-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; lot number: ER8732), via an unspecified route of administration on 30Mar2021 at 14:30(at the age of 52-years-old) administered in Arm Left as a single dose for COVID-19 immunisation at hospital. Medical history included allergies: Sulfa from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took amoxicillin and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Apr2021 at 16:30, the patient experienced Shingles that started 3 days following the 1st vaccine administration. Therapeutic measures were taken as a result of shingles and treatment included 7-day course of Valtrex. The adverse event did result Doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 1712977
Sex: M
Age:
State: NJ

Vax Date: 01/05/2021
Onset Date: 04/07/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Experiencing herpes/shingles; Experiencing herpes/shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on 05Jan2021 (Batch/Lot Number: EL0142) as dose 2, single for covid-19 immunization (at the age of 60-years-old). The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, as single dose for COVID-19 immunization. Facility type vaccine was reported as hospital. Patient had no covid prior vaccination. Patient was not tested for covid post vaccination. Patient had not received any other vaccine in four weeks. It was reported that since the second dose of the vaccine the patient experiencing herpes/shingles like reaction 07Apr2021. Ae resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events with antiviral medication. The outcome of the events was recovered on an unspecified date in 2021. No follow-up attempts are required. No further information is expected.

Other Meds:

Current Illness:

ID: 1712978
Sex: M
Age:
State: AZ

Vax Date: 03/30/2021
Onset Date: 04/14/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Shingles; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: ER8734), via an unspecified route in the right arm on 30Mar2021 at 11:45 (age at vaccination: 61-year-old), as a single dose for covid-19 immunization. Medical history included long term hypertension, under medical management. Concomitant medications included hydrochlorothiazide, lisinopril (LISINOPRIL-HCTZ), simvastatin and tamsulosin. No known allergies were reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 14Apr2021 at 04:00, patient developed a mild case of Shingles, two weeks after receiving first vaccine shot. He saw a news report on 20Apr2021 about research in (Country Name) that identified shingles as a possible side effect after the first shot. He heard similar reports on TV news today. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of the events included 7-day treatment of Valtrex. The clinical outcome of the event was recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: LISINOPRIL HCTZ; SIMVASTATIN; TAMSULOSIN

Current Illness:

ID: 1712979
Sex: M
Age:
State: NJ

Vax Date: 04/05/2021
Onset Date: 04/11/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 50-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 05Apr2021 at 09:00 AM (Batch/Lot Number: EW0151) as dose 1, single for covid-19 immunization (at the age of 50-years-old). Medical history included hypertension from an unknown date and unknown if ongoing. The concomitant medications included unspecified medication (other medications uses in two weeks prior vaccination). The patient had no known allergies. Patient had no covid prior vaccination. The patient has not been tested for covid post vaccination. Patient had not received other vaccine in four weeks. It was reported that after receiving the dose of vaccine on the patient experienced shingles on 11Apr2021. Ae resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles with Valacyclovir. The patient was not recovered from the event at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1712980
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/12/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; This is a spontaneous report from a contactable consumer (patient). A 51-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported, patient was 51-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 09Apr2021 at 06:15 PM as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history was not reported. The patient previously took humira for colitis ulcerative which can reduce my ability to fight infection. No other vaccine received in four weeks. Other medications received in two weeks. No covid prior vaccination, no covid tested post vaccination. No known allergies reported. On 12Apr2021, the patient experienced shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching. Therapeutic measures were taken as a result of shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching with Steroid ointment and cortisone cream. AE resulted in doctor or other healthcare professional office/clinic visit. The outcomes of events were recovering. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1712981
Sex: F
Age:
State: FL

Vax Date: 02/09/2021
Onset Date: 03/21/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Diagnosed with Herpes Zoster (shingles); This is a spontaneous report from a contactable consumer. This 65-year-old female consumer (patient) reported that: A 65-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 09Feb2021 at 16:30 (at the age of 65-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included High BP, High cholesterol, from an unknown date and unknown if ongoing. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medication(s) included lovastatin (LOVASTATIN); lisinopril (LISINOPRIL) and loratadine (LORATADINE) taken for an unspecified indication, start and stop date were not reported. Patient previously took penicillin and experienced allergies. Patients heroical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL3246), via an unspecified route of administration, administered in Right arm on 19Jan2021 at 16:30 (at the age of 65-year-old) as single dose for covid-19 immunisation. Patient was not received any other vaccine four weeks prior vaccination. The patient experienced diagnosed with herpes zoster on 21Mar2021 at 10:00. Since vaccination patient not tested for covid-19. Event resulted to visit Doctor or other healthcare professional office/clinic. Therapeutic measures were taken as a result of the events with Antiviral. The outcome of the event was reported as recovered on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: LOVASTATIN; LISINOPRIL; LORATADINE

Current Illness:

ID: 1712982
Sex: F
Age:
State: TN

Vax Date: 03/01/2021
Onset Date: 03/04/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: swelling, and redness is at the injection site on her left arm; swelling, and redness is at the injection site on her left arm; raised knot at injection site; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6210), via an unspecified route of administration, administered in Left arm on 01Mar2021 16:00 (at the age of 34-years-old) as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medication included sertraline 50 mg. The patient previously took bnt162b2 for covid-19 immunisation and experienced fatigue, sertraline. Patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9261), via an unspecified route of administration, administered in Left arm on 23Jan2021 as dose 1,0.3 ml, single for covid-19 immunization and experienced tiredness. Prior to vaccination, the patient did not receive any other vaccines within 4 weeks. Patient experienced, swelling, and redness is at the injection site on her left arm. It was a little more than half way down to the elbow. She stated that the COVID vaccine was administered a little low. It was given on top of her bicep and more towards her shoulder. Noticed the tight knot once she got home from receiving the COVID vaccine. On the day of this report the redness and swelling were spreading. It was the size of a quarter yesterday in the morning. Today it is the size of a plum or a little bigger than a half dollar. The outcome of the event was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE

Current Illness:

ID: 1712983
Sex: F
Age:
State: NJ

Vax Date: 03/22/2021
Onset Date: 04/16/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: menstrual cycle to start 10 days early; excessive clotting from my period; This is a spontaneous report from a contactable consumer reported for herself. A 24-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8733), dose 2 via an unspecified route of administration, administered in left arm on 22Mar2021 at 10:00 (at the age of 24-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. Historical vaccine included: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8727) (at the age of 24-years-old) as dose 1, single administered in left arm on 22Mar2021 at 18:00 PM for COVID-19 immunization. After first dose it caused menstrual disorder (menstrual cycle to start 4 days early) and dysmenorrhoea (also had cramping the day got the shot). The patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No COVID prior vaccination. Facility type vaccine reported as other. On 16Apr2021, the patient experienced menstrual cycle to start 10 days early and excessive clotting from period. Both times patient had excessive clotting from period which was not something experience with usual cycle. No treatment received for adverse event. No COVD tested post vaccination. The outcome of the events were recovering.

Other Meds:

Current Illness:

ID: 1712984
Sex: F
Age:
State: TN

Vax Date: 03/31/2021
Onset Date: 04/07/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: chills; headaches; tiredness; broke our on a rash on left side; rash was on eyelid; more rashes around eyebrows and corner of mouth and underneath lip; shingles; pigmentation; This is a spontaneous report from a contactable (patient) reported that. A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 31Mar2021 (Batch/Lot Number: ER8737) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. Facility type vaccine: Public Health Clinic/Veterans Administration facility. After the 1st shot of vaccine patient reported - regular side effects: sore arm, nausea and feeling off. The patient reported after 24 hrs. of 2nd shot of vaccine experienced chills, headaches, tiredness, no fever within 24 hrs. on 07Apr2021 and week after 2nd shot, broke out on a rash on left side. Started on forehead then by Friday, 09Apr, rash was on eyelid. Went to Eye dry sat and urgent care on Sunday for more rashes around eyebrows and corner of mouth and underneath lip. Went to dermatologist on Tuesday, 13Apr2021 and treated as shingles. The events result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On the mend now but it left some scars and pigmentation issue. The event outcome was recovering.

Other Meds:

Current Illness:

ID: 1712985
Sex: F
Age:
State: MD

Vax Date: 04/01/2021
Onset Date: 04/05/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: boil on right side of the labia; ill; nauseous; dizzy; Vertigo; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, NDC: 59267-0100-1, Expiration date: unknown), via an unspecified route of administration in arm right on 01Apr2021 (at the age of 83-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history included allergy to penicillin. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, NDC: 59267-0100-1, Expiration date: unknown), via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunization. The caller stated that, she was called because she had this number on the phone and had her second Pfizer shot on 01Apr2021 and she became ill, nauseous and dizzy on 05Apr2021. The caller stated that, she was transferred to an emergency room and the only thing they come up was that she had vertigo on 05Apr2021. Stated that, she has never had vertigo in her life, could this be vertigo or could it be a reaction to the vaccine. Treated with something for nausea, no details provided and meclizine for the dizziness, refilled yesterday at the doctor's office plus prednisone, also was taking an antibiotic because she had a boil on right side of the labia on 14Apr2021 and they lanced it. Stated that, the boil was down in the valley, clarified that, on her labia. Stated that, it has improved since taking the antibiotics. Stated that, the doctor gave her some medication, took first round and it has improved, it was still there, has not started to take the second. Stated that, first dose has same NDC number, Lot, Expirations and dosages unknown. Second dose was administered around 11am, right arm. Stated that, she got the vaccine at hospital and they knew about her allergy to penicillin and other allergies. Stated that, the caller did not know the names of the medications. The reporter seriousness for the events was reported as unspecified. The events resulted in emergency room visit. Treatment was received for the event boil on right side of the labia. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1712986
Sex: F
Age:
State: CA

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:Increase; Comments: increase of 15bpm

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Increased resting heart rate (increase of 15bpm); Painful; lots of clotting; heavy period after 1st dose; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Right Arm on 25Mar2021 14:00 (Age at vaccination 38 years old) (Batch/Lot Number: Er8730) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took neomycin and experienced drug hypersensitivity, bacitracin and experienced drug hypersensitivity, chloraprep and experienced drug hypersensitivity. On an unspecified date the patient experienced Increased resting heart rate (increase of 15bpm) Painful and heavy period after 1st dose with lots of clotting. The patient underwent lab tests and procedures which included heart rate: increase on increase of 15bpm. Outcome of the events was unknown. No follow-up attempts are required. No further information is expected.

Other Meds:

Current Illness:

ID: 1712987
Sex: M
Age:
State: LA

Vax Date: 03/19/2021
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood Pressure; Result Unstructured Data: Test Result:118-128/ 80-86; Test Name: Blood Pressure; Result Unstructured Data: Test Result:130-164/ 90-102

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Arm and site pain only.; Arm and site pain only.; My blood pressure is up from pre shot range. 118-128/ 80-86. Now 130-164/ 90-102; This is a spontaneous report from a contactable consumer, the patient. A 62-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208, expiration date not reported), via an unspecified route of administration, administered in left arm on 19Mar2021 (at the age of 62 years) as dose 2, single for covid-19 immunization. Medical history included coronary artery disease, contact dermatitis, both on unknown if ongoing, and ongoing hypertension, all from an unknown date. Patient had known allergies to Penicillin, tylox and lotrel. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6200, expiration date not reported) via unspecified route of administration, administered in left arm on 26Feb2021 (at the age of 62 years) as dose 1, single for covid-19 immunization and experienced arm pain. Patient did not take other vaccine in four weeks. Concomitant medication included amlodipine besilate, benazepril hydrochloride; and rosuvastatin, both taken for an unspecified indication, start and stop date were not reported. On an unknow date, the patient experienced arm and site pain only. Patient blood pressure was up from pre shot range 118-128/ 80-86, now 130-164/ 90-102. Patient did not had covid prior to vaccination and had not been tested for covid since the vaccination. Events resulted in doctor or other healthcare professional office/ clinic visit. Treatment taken for events was unknown. The outcome of all the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE; ROSUVASTATIN

Current Illness: Hypertension

ID: 1712988
Sex: F
Age:
State: TN

Vax Date: 03/18/2021
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: I had a herpes ( shingles breakout after each vaccine. More severe after second dose.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Left on 18Mar2021 16:30 (at the age of 56 years) (Batch/Lot Number: EP7534) as DOSE NUMBER UNKNOWN, SINGLE via an unspecified route of administration, administered in Arm Left on 26Feb2021 (at the age of 56 years) (Batch/Lot Number: EN6299) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at Public Health Clinic. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. Patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Feb2021 the patient experienced I had a herpes (shingles breakout after each vaccine. More severe after second dose). The treatment received for the event was unknown. The clinical outcome of the event was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1712989
Sex: M
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: BP; Result Unstructured Data: Test Result: 120/78; Comments: Mine is normally 120/78; Test Date: 20210417; Test Name: BP; Result Unstructured Data: Test Result: 155/102; Comments: BP was 155/102.

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: sore arm; feeling pressure in my chest; chills; fatigued; chest was pounding; BP was 155/102. Mine is normally 120/78 so very high for me; This is a spontaneous report from a contactable consumer. A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER6955, Expiration date was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 16Apr2021 14:45 (age at vaccination 44 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no allergies. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP6955, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 19Mar2021 14:45 as dose 1, single for covid-19 immunisation and suffered from sore pain. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 19:00 the patient experienced sore arm, feeling pressure in my chest, chills, fatigued, fell asleep at 9:00 pm, woke up at 10:30 pm chest was pounding, bp was 155/102. mine is normally 120/78 so very high for me. The patient underwent lab tests and procedures which included blood pressure measurement was 120/78 (Mine is normally 120/78), blood pressure measurement was 155/102 on 17Apr2021 BP was (155/102). Patient did not receive any treatment for occurred events. The outcome of event was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1712990
Sex: F
Age:
State: NC

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: SEVERE headache that will not go away.; Chills; Fever; Body aches; Lethargy; Lymph node swelling and pain; Lymph node swelling and pain; Rash on face; painful sores on scalp; painful sores on scalp; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 42-year-old female patient received BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- UNKNOWN) via an unspecified route of administration in right arm on 19Apr2021 as dose 2, single (at the age of 42-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history was reported as none. Patient had no known allergies. The concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 28Mar2021 15:00 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks. The patient experienced severe headache that will not go away, chills, fever, body aches, lethargy, lymph node swelling and pain, rash on face, painful sores on scalp, on 20Apr2021. The patient did not receive any treatment for the events. Facility type vaccine was Pharmacy or drug store. The outcome of the events was resolved with sequelae on an unspecified date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1712991
Sex: F
Age:
State: TX

Vax Date: 02/27/2021
Onset Date: 03/23/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210406; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: I developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. I even went to my neurologists office for an IV treatment. After 8-9 days of he; developed shingles rash on my right thigh and next to my right knee; extremely painful and itchy; extremely painful and itchy; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL6202 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 27Feb2021 10:30 as DOSE 1, SINGLE for covid-19 immunization. Medical history included migraine from an unknown date and unknown if ongoing Relevant medical history: Migraine , bronchiectasis from an unknown date and unknown if ongoing Relevant medical history: bronchiectasis , pain from an unknown date and unknown if ongoing Relevant medical history: chronic pain , depression from an unknown date and unknown if ongoing Relevant medical history: depression. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination. The patient was not diagnosed with Covid 19 and has been tested for Covid-19 Since the vaccination. The patient previously took codeine and experienced drug hypersensitivity, sumatriptan and experienced drug hypersensitivity, levaquin and experienced drug hypersensitivity, bactrim and experienced drug hypersensitivity. On 23Mar2021 15:00 the patient experienced i developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. i even went to my neurologists office for an iv treatment. after 8-9 days of he, developed shingles rash on my right thigh and next to my right knee, extremely painful and itchy. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 06Apr2021 .Therapeutic measures were taken as a result of i developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. i even went to my neurologists office for an iv treatment. after 8-9 days of he, developed shingles rash on my right thigh and next to my right knee, extremely painful and itchy, extremely painful and itchy , treatment included for Migraine, Antiviral meds for rash. The outcome of event was recovering. No Follow-up attempts are needed. No further Information is expected.

Other Meds:

Current Illness:

ID: 1712992
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/18/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: rash developed 23Apr; Diagnosed with Shingles on 4-23-21; skin sensitivity on thigh on 18Apr; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0151, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 08Apr2021 14:30 at the age of 56-year-old as dose 1, single for COVID-19 immunization, at pharmacy. The patient medical history included DVT (deep vein thrombosis) and PE (pulmonary embolism) in 2014. The patient had known allergies to sulfa drugs and latex. The concomitant medications included Multivitamins. The patient was not pregnant at the time of vaccination. The patient received no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. It was reported that, the first symptoms appeared skin sensitivity on thigh on 18Apr2021 at 20:00. The patient was diagnosed with shingles on 4-23-21 and rash developed on 23Apr2021 at 20:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received antivirals as treatment for the events. The outcome of the events was reported as resolving.

Other Meds:

Current Illness:

ID: 1712993
Sex: F
Age:
State: WI

Vax Date: 03/29/2021
Onset Date: 04/11/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Herpes zoster (shingles); This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: ER8733) via an unspecified route of administration (age at vaccination 52-year) in left arm on 29Mar2021 at 10:45 AM as dose 1, single for COVID-19 immunization. Medical history included gitelman's syndrome, COVID-19 (Prior vaccination), both from an unknown date and unknown if ongoing If. Concomitant medications included metoprolol; topiramate; erenumab aooe (AIMOVIG); acetaminophen (Excedrin TH); gliclazide, metformin hydrochloride (WALFORMIN); all medications taken in twoweeks of vaccination, for an unspecified indication, start and stop date were not reported. Patient received no other vaccine in fourweeks. The patient not tested COVID post vaccination. No known allergies were reported. On 11Apr2021 at 09:30 PM the patient experienced herpes zoster (shingles) of trigeminal nerve with ocular involvement. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of herpes zoster, the patient was treated with antiviral medication (valacyclovir). The clinical outcome of the event was resolving. No follow-up attempts are required. No further information is expected.

Other Meds: METOPROLOL; TOPIRAMATE; AIMOVIG; ACETAMINOPHEN; WALFORMIN

Current Illness:

ID: 1712994
Sex: F
Age:
State: FL

Vax Date: 03/31/2021
Onset Date: 04/10/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: I developed Shingles two weeks after receiving my first vaccination; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 63-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP075333), via an unspecified route of administration, administered in arm left on 31Mar2021 at 13:30 (01:30 PM) (at the age of 63-year-old) as dose 1, single for COVID-19 immunization. Medical history included GERD and known allergies: PCN. The patient concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination. Patient had not been COVID tested post vaccination. On 10Apr2021, the patient experienced I developed shingles two weeks after receiving my first vaccination. AE resulted in doctor or other healthcare professional office/clinic visit. Adverse event: I developed Shingles two weeks after receiving my first vaccination and wondering if this is a side effect. Just read an article regarding herpes rash as a side effect. The patient received Antiviral and topical cream as a treatment medication for the event. Outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 1712995
Sex: M
Age:
State: TX

Vax Date: 04/09/2021
Onset Date: 04/18/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: This is a spontaneous report from a contactable consumer. This 28-year-old male consumer (patient) reported. A 28-year-old male patient received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in right arm on 09Apr2021 12:30 PM (at the age of 28-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 18Apr2021 12:00 PM, after the vaccination, the patient experienced Shingles and skin tenderness began. On 22Apr2021 patient experienced Rash. Patient received Valacyclovir for shingles as treatment option. Patient took no other vaccines in four weeks and no other medications in two weeks. The patient was not diagnosed with covid prior vaccination and patient was tested covid post vaccination. No known allergies found. The outcome of the events was recovering at the time of this report. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1712996
Sex: M
Age:
State: SC

Vax Date: 03/17/2021
Onset Date: 03/22/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Shingle outbreak 5 days after first shot in area of left side of neck, ear and back of head; Blister and extreme pain; Blister and extreme pain; Nerve pain; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 52-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207), via an unspecified route of administration, administered in Arm Right on 17Mar2021 18:00 as dose 1, single and a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0161), via an unspecified route of administration, administered in Arm Right on 13Apr2021 18:00 (at the age of 52-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were nor reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient had no health issues prior to vaccine. Patient received vaccine Facility in Hospital. On 22Mar2021 03:00, shingle outbreak 5 days after first shot in area of left side of neck, ear and back of head. Blister and extreme pain that required doctor care. Completed 10 days of prescribed medicine and was getting better. 2nd outbreak occurred after getting 2nd Covid vaccine. Same area, but less blistering. Still extreme nerve pain. Treatment was received for the events as Valacyclovir for 10 days. Patient visited Doctor or other healthcare professional office/clinic visit. The outcome of the events was reported as recovering. Follow-Up (15Sep2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1712997
Sex: M
Age:
State: WI

Vax Date: 04/13/2021
Onset Date: 04/19/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Shingles/Shingle site located on septum of nose; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0164) via an unspecified route of administration, administered in Arm Right on 13Apr2021 17:30 (at the age of 47 years old) as dose 2, single for COVID-19 immunisation at Public Health Clinic/Veterans Administration facility. Medical history reported as none. Concomitant medication within two weeks included atorvastatin (ATORVASTATIN), eicosapentaenoic acid ethyl ester (VASCEPA), levothyroxine sodium (LEVOTHYROXIN), all taken for an unspecified indication, start and stop date were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8733) via an unspecified route of administration, administered in Arm Right on 23Mar2021 17:30 (at the age of 47 years old) as single for COVID-19 immunisation. Patient did not received other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced shingles/shingle site located on septum of nose on 19Apr2021 08:00. Event reported as, Shingles diagnosed by PhD medical professional. Shingle site located on septum of nose. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment included anti-viral prescribed and ophthalmolog appointment. Patient did not tested for COVID post vaccination. Outcome of the event was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; VASCEPA; LEVOTHYROXIN

Current Illness:

ID: 1712998
Sex: M
Age:
State: RI

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210420; Test Name: Nasal Swab; Test Result: Positive

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Shingles; Pain in my right knee; I had pain in my right leg moving around between thigh groin and knee; I had pain in my right leg moving around between thigh groin and knee; As I received my vaccine I immediately got pain in my right knee. Found it strange. Each day following for 4 days I had pain in my right leg moving around between thigh groin and knee. Day 5 rash brok; As I received my vaccine I immediately got pain in my right knee. Found it strange. Each day following for 4 days I had pain in my right leg moving around between thigh groin and knee. Day 5 rash brok; This is a spontaneous report from a contactable consumer (Patient). A 60-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEHC COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection via an unspecified route of administration, administered in Arm Left on 16Apr2021 17:45 (at the age of 60-year-old) as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included tetanus vaccine (TETANUS VACCINE) on 01Apr2021, metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET) and atorvastatin calcium (ATORVASTATIN CALCIUM). Patient had no known allergies. Patient was not diagnosed with COVID-19 prior vaccination. On 21Apr2021, the patient experienced shingles, pain in my right knee, had pain in my right leg moving around between thigh groin and knee, as he received vaccine immediately got pain in right knee. found it strange. each day following for 4 days had pain in right leg moving around between thigh groin and knee. day 5 rash brok. It was reported that, as he received his vaccine he immediately got pain in his right knee. Found it strange. Each day following for 4 days he had pain in his right leg moving around between thigh groin and knee. Day 5 rash broke out and was determined to be Shingles. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 20Apr2021. Therapeutic measures were taken as a result of adverse events, antiviral drug and pain meds. Event resulted into emergency Room and physician office visit. The outcome of events was recovering. The lot number for [BNT162B2], was not provided and will be requested during follow up.

Other Meds: JANUMET; ATORVASTATIN CALCIUM

Current Illness:

ID: 1712999
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: left temporal headache; Shingles; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: ER8729) via an unspecified route of administration in arm left on 21Apr2021 12:45 as dose 2, single (age at vaccination: 57 years) for COVID-19 immunisation. Medical history included multifocal GBM responsive, chicken pox as a child to treatment, both from an unknown date and unknown if ongoing. Concomitant medications included simvastatin (AVASTIN [SIMVASTATIN]) infusion; temozolomide (TEMODAR) oral, both taken for an unspecified indication, start and stop date were not reported. Historical vaccine includes bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EP7534) via an unspecified route of administration in arm right on 23Mar2021 01:00 as dose 1, single for COVID-19 immunisation. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No covid prior vaccination and did not tested COVID post vaccination. No known allergies. On 22Apr2021 at 12:00, the patient experienced left temporal headache reduced by Tylenol for two days, followed by small outbreak of shingles on left front scalp. No treatment received and no history of shingles. The clinical outcome of the event left temporal headache was resolving and the event shingles was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: AVASTIN [SIMVASTATIN]; TEMODAR

Current Illness:

ID: 1713000
Sex: M
Age:
State: NJ

Vax Date: 04/20/2021
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: her husband cut his hand and was in the emergency room and had stitches; Arm hurts a little bit; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (BNT162B2) formulation solution for injection, dose 2 (Lot number and expiry date was not reported) via an unspecified route of administration on 20Apr2021 as a single for covid-19 immunisation. Medical history included Parkinson's disease from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Reported stated that her husband received his second dose of the Covid 19 Vaccine yesterday. Yesterday afternoon he was walking down the street with a glass bottle in his hand. He fell and the bottle broke and cut his hand. Reporter stated her husband has Parkinson's Disease. Reporter took her husband to the doctor after his fall and the doctor put him on Antibiotics and wanted to give him a Tetanus Vaccine. She is calling to see how soon after the Covid 19 Vaccine he will be able to get this Tetanus Vaccine; he has not received it yet. Reporter was declining to complete report. She stated she's not reporting anything to do with the shot. Says her husband has Parkinson's Disease and he falls all of the time. Stated the fall he had was not related to his vaccination. She said the only thing he had related to the vaccine was his arm hurts a little bit. Reporter said when she went to pick up her husband's antibiotics the pharmacist told her that he would have to wait until two weeks after his Covid 19 Vaccine to get any other vaccinations. including the Tetanus Vaccine. Reporter stated she just wants to be transferred so they can tell her if 2 weeks is the correct amount of time. Also asks if the second dose of the vaccine has to be right at 3 weeks from the first dose. Outcome of the events was unknown No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713001
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/13/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: I started menstruating again (note, this is only 2 weeks after my previous period)/lasted 7 days - nearly twice my usual period length; It was more than twice my usual flow; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 43 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included food allergy to mango from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced normal menstruation on 29Mar. It lasted its usual 3-4 days. A week later, on 07Apr, she had the first dose of the Pfizer vaccine. A week after that, on 13Apr, she started menstruating again, this is only 2 weeks after her previous period. This menstruation was extremely unusual. It started mid-cycle, when she normally is very regular. It was not accompanied by any of the usual PMS symptoms, like sore breasts or fatigue. It was more than twice her usual flow and lasted 7 days which is nearly twice her usual period length causing menstrual disorder and heavy menstrual bleeding on 13Apr2021 with outcome of unknown. No follow-up attempts are possible; information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713002
Sex: F
Age:
State: IA

Vax Date: 03/28/2021
Onset Date: 04/19/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Vesicular rash noted on back 22 days post vaccine Diagnosed as shingles; Vesicular rash noted on back 22 days post vaccine Diagnosed as shingles; This is a spontaneous report from a contactable other healthcare professional. A 39 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 28Mar2021 10:45 (Batch/Lot Number: EF8732) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity to Penicillin, sulpha from an unknown date and unknown if ongoing. There were no concomitant medications. The patient experienced vesicular rash noted on back 22 days post vaccine diagnosed as shingles or Herpes Zoster on 19Apr2021 20:00 with outcome of recovering. The patient had to visit physician office. Therapeutic measures were taken as a result of the events with Valtrex Follow-Up (15Sep2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1713003
Sex: F
Age:
State: NY

Vax Date: 03/06/2021
Onset Date: 03/14/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Shingles; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6203), dose 1 via an unspecified route of administration in left arm on 06Mar2021 at 13:30 (at the age of 69-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included Sulfa (drug allergy) from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing. Concomitant medications included atenolol, dexlansoprazole (DEXILANT), levothyroxine sodium (SYNTHROID), pitavastatin calcium (LIVALO), colecalciferol (VITAMIN D 3); all from unknown dates to unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced shingles on 14Mar2021. The adverse event was resulted in doctor or other health care professional office/clinic visit. Anti-viral and topical cream was given as a treatment for event. The outcome of the event was reported as resolved on an unknown date. Follow-up attempts are completed. No further information is expected.

Other Meds: ATENOLOL; DEXILANT; SYNTHROID; LIVALO; VITAMIN D 3

Current Illness:

ID: 1713004
Sex: F
Age:
State: MI

Vax Date: 04/12/2021
Onset Date: 04/21/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Continuing Fatigue two weeks after second dose.; Extreme heavy menstrual period with clotting; Extreme heavy menstrual period with clotting; This is a spontaneous report from a contactable consumer. A 29-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm Left on 12Apr2021 at 17:30 as DOSE 2, SINGLE (at the age of 29-year-old) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received dose 1 on 22Mar2021 at 05:30 PM (Batch/Lot number: Unknown) for covid-19 immunisation. On 21Apr2021 at 04:30 PM, patient continued fatigue two weeks after second dose. Extreme heavy menstrual period with clotting that did not occur with prior periods. AE resulted in Emergency room/department or urgent care. It was unknown if the patient received the treatment or not. The outcome of the events was not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713005
Sex: F
Age:
State: OH

Vax Date: 02/19/2021
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: the sores were so bad; shingles; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 66-year-old Elderly female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: E19266), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 (at the age of 66-year-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included sarcoidosis from an unknown date and unknown if ongoing. The patient had no covid prior vaccination. The patient had no Known allergies. Concomitant medication(s) included Prednisone; Azathioprine; Gabapentine and ?'Hydoxychor''all taken for an unspecified indication, start and stop date were not reported. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9261), via an unspecified route of administration, administered in Left arm on 30Jan2021 (at the age of 66-year-old), as single for covid-19 immunisation and had sores on her left back hip. The patient had no other vaccine in four weeks. The patient had not been covid tested post vaccination. On an unspecified date in 2021, after the second dose, the patient experienced sores that were so bad and shingles. It was reported that the shingles was diagnosed after the second does when the sores were so bad, she went to her internist who referred her to dermatologist and was diagnosed with Shingles. The AE resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received to treat the events. The patient outcome of the events was resolved on an unspecified date in 2021. No follow-up attempts are possible, information. No further information is expected.

Other Meds: Prednisone; Azathioprine; Gabapentin

Current Illness:

ID: 1713006
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 04/14/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: Strep Throat; Test Result: Positive

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Throat infection (Strep Throat Positive); scar; Pityriasis Rosea; This is a spontaneous report from a contactable consumer (patient herself). A 23-years-old non-pregnant female patient received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: EW0150, Expiry date: Unknown) via an unspecified route of administration in Arm Left on 07Apr2021 09:15 as dose 1, single (at the age of 23 years) for COVID-19 immunization. The patient medical history was not reported and there were no concomitant medications. There were no known allergies. Prior to vaccination, patient did not have COVID-19. Covid-19 was not tested post vaccination. On 14Apr2021, the patient first noticed a scar appearing on Chest, Pityriasis Rosea and on 21Apr2021, experienced throat infection. The scar started growing over a couple of days into a circular Herald Patch appearance. Along with the growth of that one patch, smaller scars started appearing on left side of lower back. Since then, the smaller ones have grown into an almond shape larger appearance. Similar smaller ones have been noticed on underarm and appears as though more are starting to appear on stomach. Patient went to Clinic for consolation and doctor suspects it could be a reaction to vaccination and that it looks like a case of Pityriasis Rosea. No irritation or itching was reported. Purely visible with no symptoms of irritation. Therapeutic measures were taken for throat infection (Strep Throat Positive) and have been on Ibuprofen and Antibiotics (Penicillin) and therapeutic measures were not taken for other events. The outcome of the events was reported as not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1713007
Sex: F
Age:
State: PA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210416; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: my left arm went numb. My pinky and ring finger was numb and tingly; my left arm went numb. My pinky and ring finger was numb and tingly; felt cold; I had the sensation from the top of my head down to my foot.; I had pain in my hip; I alerted the doctor on staff and was told the nurse probably hit a nerve.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 36-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:30 (at the age of 36years) (Batch/Lot Number: EP7533) as DOSE 1, SINGLE for Covid-19 immunization at Hospital. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Medical history included mild asthma and Arrowroot (food allergy) from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid, beta carotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10 [ASCORBIC ACID; BETACAROTENE; CUPRIC OXIDE; MANGANESE SULFATE; SELENIUM; TOCOPHERYL ACETATE; UBIDECARENONE; ZINC OXIDE]); folic acid and omega-3 fatty acids (OMEGA-3 FATTY ACIDS) taken for an unspecified indication, start and stop date were not reported. The patient stated, on 06Apr2021 11:30AM ''Immediately after my first dose my left arm went numb. My pinky and ring finger was numb and tingly and felt cold. I had the sensation from the top of my head down to my foot. I still feel it now through the nerves going to my spine on my left side, my IT band, triceps, wrist arm, head, literally my entire left side. I had pain in my hip as well. 3 weeks later I have the same numbness in my fingers, head, face, back, and leg. I alerted the doctor on staff and was told the nurse probably hit a nerve''. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 16Apr2021. The clinical outcome of the events was not recovered at the time of vaccination.

Other Meds: COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECA; FOLIC ACID; OMEGA-3 FATTY ACIDS

Current Illness:

ID: 1713008
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Shingles; This is a spontaneous report from a non-contactable consumer or other non hcp. A 38-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No was not reported), via an unspecified route of administration on 16Apr2021 14:00 as dose number unknown, single for covid-19 immunisation (age at vaccination was 38 years). Medical history included drug hypersensitivity from an unknown date and unknown if ongoing (penicillin allergy). The patient's concomitant medications were not reported.The patient experienced shingles on 17Apr2021 10:00.Therapeutic measures were taken as a result of shingles. Treatment was received. Outcome of the event was recovering. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1713009
Sex: M
Age:
State: NJ

Vax Date: 03/13/2021
Onset Date: 03/16/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: I developed shingles 2 days after getting the 1st dose of Pfizer vaccine.; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), first dose via an unspecified route of administration, administered in left arm on 13Mar2021 at 13:00 (at the age of 74-year-old) as dose 1, single for COVID-19 immunisation at military base. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP, hypertension from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP. No known allergies were reported. The patient's concomitant medications in two weeks of COVID-19 vaccination included blood pressure, cholesterol, multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that on 16Mar2021, the patient developed shingles 2 days after getting the 1st dose of Pfizer vaccine. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Unspecified medication was given as treatment for the events. The outcome of the event was reported as resolved with lasting effects. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713010
Sex: F
Age:
State: SC

Vax Date: 03/26/2021
Onset Date: 04/09/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Shingles; exhausted; pain/ache; general malaise; burning; stinging nerve pain; This is a spontaneous report from a contactable other HCP (patient). A 28-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration in arm right on 26Mar2021 11:45 as dose 1, single (age at vaccination: 28 years) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks. No COVID prior vaccination and did not tested COVID post vaccination. On 09Apr2021 at 12:30 PM, the patient experienced shingles, symptoms began approx 1 week post dose, exhausted, ache, pain, general malaise. Started with burning, stinging nerve pain inner right thigh also located on right side of scalp. Lesions approx 2 weeks post dose. Started antivirals. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received was antivirals. The clinical outcome of the events was resolving. No follow up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713011
Sex: F
Age:
State: IN

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Shingles; Blisters; This is a spontaneous report from a contactable consumer or other non hcp. A 45-years-old non-pregnant female patient received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 17Apr2021 (age at vaccination: 45Years) as DOSE 2, SINGLE for covid-19 immunisation. Patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: not reported) via unspecified route of administration on 27Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. Patient was pregnant at the time of vaccination. Medical history included colitis ulcerative from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no allergies, patient didn't had covid prior to vaccination. On 19Apr2021 16:00 the patient experienced shingles, blisters. No therapeutic measures were taken for the events. Patient was not tested for covid to post vaccination. The outcome of the events herpes zoster, blister was recovering. No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1713012
Sex: F
Age:
State: CA

Vax Date: 04/08/2021
Onset Date: 04/15/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Shingles; This is a spontaneous report from a contactable consumer (patient herself) via COVID-19 Adverse Event Self-Reporting Solution (COVAES). A 52 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ew0153) via an unspecified route, administered in Right Arm on 08Apr2021 at 13:30 (52-year-old at vaccination) as a Dose 1, Single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history included known allergies to Penicillin, Sulfa drugs. The patient's concomitant medications were not reported. The patient previously took septra and experienced allergy. Facility type vaccine was reported as Other. The patient was not diagnosed for Covid prior vaccination. The patient had not received any other vaccine within four weeks prior to vaccination. On 15Apr2021, the patient experienced shingles. Ae resulted in Doctor or other healthcare professional office/clinic visit. The patient was not tested for covid post vaccination. No treatment received for the event. The outcome of the events was Not recovered.

Other Meds:

Current Illness:

ID: 1713013
Sex: F
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: a severe nosebleed; a severe nosebleed with clotting; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (daughter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an un-specified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. It was mentioned that, just wanted to update about a reaction patient had that was associated with recent vaccination. Patient (my daughter) had a severe nosebleed with clotting after second COVID19 vaccination. The outcome of the events were unknown. The lot number was not provided. Information on lot number has been requested during follow up.

Other Meds:

Current Illness:

ID: 1713014
Sex: M
Age:
State: NY

Vax Date: 02/26/2021
Onset Date: 03/05/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; Severe Pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulde; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old male patient received bnt162b2 (BNT162B2), dose 2 (Lot number and expiry date was not reported) via an unspecified route of administration at arm left on 26Feb2021 07:00 (at the age of 56-years-old) as a single for covid-19 immunisation. Medical history included hypergammaglobulinemia benign monoclonal, food allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included finasteride taken for an unspecified indication, start and stop date were not reported. Historical Vaccine BNT162B2 dose 1 (lot number and expiry date was unknown) via unspecified route of administration aa a single dose for COVID-19 immunisation. Severe Pain started in injection arm went up neck then into shoulder ? in pain for 5 days till a rash came out on fifth day which Doctor said was Shingles - still in nerve pain in left arm and shoulder in 7th week - started 05Mar2021 19:00 pain. Still in nerve pain in left arm and shoulder. Therapeutic measures were taken as a result of severe pain started in injection arm went up neck then into shoulder - in pain for 5 days till a rash came out on fifth day which doctor said was shingles - still in nerve pain in left arm and shoulder. Outcome of the events was not recovered.

Other Meds: PROPECIA

Current Illness:

ID: 1713015
Sex: F
Age:
State: NJ

Vax Date: 04/20/2021
Onset Date: 04/23/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210427; Test Name: Diagnosed with shingles; Result Unstructured Data: Test Result:shingles

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: shingles; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 61-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0170), via an unspecified route of administration (at the age of 61-years), administered in arm left on 20Apr2021 at 14:30 as dose 2, single for COVID-19 immunization. Medical history included none from an unknown date and unknown if ongoing. There were no concomitant medications. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8733), via an unspecified route of administration, administered in arm left on 30Mar2021 at 14:45 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and has not been tested for covid post vaccination. The patient had no known allergies. The vaccine facility type was reported as other. No other medications were received within two weeks. On 23Apr2021, the patient experienced shingles. It was reported that symptoms were started 2 or 3 days after the vaccine on 20Apr21 and prescribed valacyclovir on 27Apr2021. The treatment was received for the adverse event with valacyclovir 1gm 3 for 7 days. The adverse events resulted in physician office visit. The patient underwent lab tests and procedures which included investigation: shingles on 27Apr2021. The clinical outcome of the event was reported as recovering.

Other Meds:

Current Illness:

ID: 1713016
Sex: F
Age:
State: NY

Vax Date: 04/06/2021
Onset Date: 04/01/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Excessively heavy period about 3 weeks after second shot; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 23-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 06Apr2021 14:00 as DOSE 2, SINGLE for covid-19 immunization (23 year when vaccinated) at public health clinic. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 16Mar2021 14:00 as DOSE 1, SINGLE for covid-19 immunization (23 year when vaccinated) and experienced irregular periods and heavy menstrual bleeding. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient medical history and concomitant medications were not reported. On an unknown date in Apr2021, the patient reported that since having both the vaccination the patient has been having excessively heavy period about 3 weeks after second shot with huge clots, and she bleeds so much that she soaked through tampon and pad in an hour. The patient had to visit the doctor in the emergency room. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for the events. The outcome of the event was reported as unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1713017
Sex: F
Age:
State: GA

Vax Date: 02/09/2021
Onset Date: 02/23/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: I got shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for herself). A 81-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: en9581), via an unspecified route of administration, administered in arm right on 09Feb2021 at 10:00 AM (at the age of 80-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: 9037765622), via an unspecified route of administration, administered in arm right on 19Jan2021 (at the age of 81-year-old) as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. On 23Feb2021, the patient experienced I got shingles. AE resulted in emergency room/department or urgent care. The patient received Gabapentin as a treatment medication for the event. Outcome of the event was recovering. Follow-up (PRD/SRD 15Sep2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1713018
Sex: F
Age:
State: CA

Vax Date: 02/12/2021
Onset Date: 04/22/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Shingles - Herpes Zoster; This is a spontaneous report received from a contactable consumer or other non hcp. A 39-years-old female patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL9266), via an unspecified route of administration on 12Feb2021 09:00,at the age of 39 years old, as Dose 1,single for covid-19 immunization.Medical history included parkinson's disease, thyroiditis, cholecystectomy from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported.The patient experienced shingles- herpes zoster on 22Apr2021.Therapeutic measures were taken as a result of shingles - herpes zoster.The outcome of the events was not recovered.The patient received Valacyclovir as treatment.The patient had not received any other vaccines within 4 weeks.The patient was not diagnosed with covid prior to vaccination and not tested post vaccination.The patient reported no allergies. No follow up attempts are needed: No further informations are expected.

Other Meds: ZYRTEC ALLERGY

Current Illness:

ID: 1713019
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: hives; shingles; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 40 year old adult female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced hives causing urticaria and shingles leading to herpes zoster on an unspecified date with outcome of unknown. The adverse events led to physician office visit. Therapeutic measures were taken as a result of this. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1713020
Sex: F
Age:
State: CA

Vax Date: 04/19/2021
Onset Date: 04/21/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: vesicular rash and redness developed 2 days after covid vaccine. Being treated for shingles/cutaneous herpes zoster; vesicular rash and redness developed 2 days after covid vaccine. Being treated for shingles/cutaneous herpes zoster; This is a spontaneous report received from a contactable nurse (patient). A 51-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0153), via intramuscular in left arm on 19Apr2021 at 13:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation at hospital. Medical history included myelodysplastic syndrome from an unknown date and unknown if ongoing, chicken pox from an unknown date and unknown if ongoing (as a child), thrombocytopenia from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) and multivitamin taken for an unspecified indication, start and stop date were not reported. The patient previously took morphine, demerol apap, vicodin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced vesicular rash and redness developed 2 days after covid vaccine (21Apr2021). being treated for shingles/cutaneous herpes zoster. Device Date was 27Apr2021. The case was reported as non-serious. The adverse events were resulted in emergency room/department or urgent care. Anti-viral, antipruritic, and pain medications were received as treatment for the events. The outcome of the events was reported as resolving. No follow-up attempts are needed. No further information is expected. Follow-up attempts are completed. No further information is expected.

Other Meds: BABY ASPIRIN.

Current Illness:

ID: 1713021
Sex: M
Age:
State: CT

Vax Date: 04/04/2021
Onset Date: 04/04/2021
Rec V Date: 09/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Severe pain of the left arm; left chest pain; Severe pain of the left arm; left chest pain; This is a spontaneous report received from a non-contactable consumer or other non hcp.A 56 years old adult male patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 04Apr2021 10:00,at the age of 56 years old, as Dose 2,single for covid-19 immunization.The patient medical history was not reported.There were no concomitant medications.The patient experienced severe pain of the left arm; left chest pain on 04Apr2021 02:00.The outcome of the events was recovering.The patient previously received his 1st dose of Pfizer covid vaccine on 14Mar2021,01:45 PM.The patient was not diagnosed with covid prior vaccination and not tested post vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am